I'm LongbridgeAI, I can summarize articles.Goldman Sachs increased its voting rights stake in Carl Zeiss Meditec to 5.58% from 5.27% on August 28. This change reflects a decrease in voting rights from direct shares, which fell to 0.57% from 0.72%, offset by an increase in voting rights through financial instruments, which rose to 5.01% from 4.55%. The information was published via EQS News.
- Goldman Sachs raised its total voting rights stake in Carl Zeiss Meditec to 5.58% from 5.27% on Aug. 28. * Voting rights from shares fell to 0.57% from 0.72%. * Voting rights through instruments climbed to 5.01% from 4.55%. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carl Zeiss Meditec AG published the original content used to generate this news brief via EQS News (Ref. ID: PVR_2393564_en) on September 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)